Racial disparities in utilization and effectiveness of first-line therapies in metastatic castrate-resistant prostate cancer.

e17541Background: Prospective evidence suggests that abiraterone use is associated with improved progression-free survival in African-American (AA) men with metastatic castrate-resistant prostate c...